Editorial, Opinion Pieces Address Various Aspects Of COVID-19 Pandemic, Including Need To Protect Gains, Sustain Momentum On Other Diseases; Potential Benefits Of Joining COVAX; Importance Of International Research Collaboration
Devex: Opinion: COVID-19 is a turning point for infectious diseases
Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria (9/16).
Foreign Affairs: America Needs to Lock Down Again
Michael T. Osterholm, Regents professor and director of the Center for Infectious Disease Research and Policy at the University of Minnesota, and Mark Olshaker, writer and documentary filmmaker (9/16).
Foreign Policy: Joining COVAX Could Save American Lives
Eric A. Friedman, global health justice scholar at the O’Neill Institute and project leader for the Platform for a Framework Convention on Global Health (FCGH), and colleagues (9/15).
Nature: Keep collaboration open when doors are closing
Editorial Board (9/15).
Nature: Study the role of hubris in nations’ COVID-19 response
Martha Lincoln, cultural and medical anthropologist and assistant professor at San Francisco State University, California (9/15).
Project Syndicate: The COVID Silver Linings Playbook
Mohamed A. El-Erian, chief economic adviser at Allianz, president elect of Queens’ College, senior adviser at Gramercy, and part-time practice professor at the Wharton School at the University of Pennsylvania (9/15).
Scientific American: We Can’t Allow the CDC to Be Tainted by Politics
Richard E. Besser, president and CEO of the Robert Wood Johnson Foundation (9/15).
USA TODAY: 3 billion people can’t wash their hands in COVID-19 pandemic. Here’s how we plan to help
Rep. Earl Blumenauer (D-Ore.) and Rep. Darin LaHood (R-Ill.), founders and co-chairs of the Congressional International Water and Sanitation Caucus (9/15).
Washington Post: Nobody wants vaccine trials to fail. But they just might
Peter G. Lurie, president of the Center for Science in the Public Interest (9/15).